צמיחת מכירות ב-12 חודשים נגררים: Precigen, Inc. (PGEN)

Precigen, Inc. (PGEN) is optimizing drug delivery through external partners and contract manufacturing. The TTM revenue trend illustrates the company's operational resilience, while 2398.70 indicates the current level. UltraCAR-T technology promises to revolutionize hospital-based cell production, yet a high dependence on venture oncology developments creates significant investment risks.
Precigen Inc (PGEN) - פילוחי מדדים ודוחות פיננסיים

For the biotechnology company Precigen, Inc. (PGEN), which has no commercial products, this indicator serves as a marker for the inflow of external financing and licensing payments. Analyzing the 12-month revenue growth rate year-over-year via a TTM rolling window smooths out reporting gaps, allowing investors to assess the dynamics of operating receipts and the financial stability of the business during the clinical development period.